ALEXANDRIA, Va., July 16 -- United States Patent no. 12,358,904, issued on July 15, was assigned to Atomwise Inc. (San Francisco).
"Inhibitors of TYK2" was invented by Shahab Mortezaei (San Francisco).
According to the abstract* released by the U.S. Patent & Trademark Office: "In exemplary embodiments, inhibitors of Tyrosine Kinase 2 (TYK2), pharmaceutical formulations comprising these compounds, methods of using these compounds to inhibit TYK2, and treat diseases such as autoimmune and inflammatory diseases are provided."
The patent was filed on June 3, 2024, under Application No. 18/732,301.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=...